Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge

by biblioteca on 18 de novembre de 2024 with No hi ha comentaris

Martínez-Vila, C., González-Navarro, E. A., Teixido, C., Martin, R., Aya, F., Juan, M., & Arance, A. (2024). Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge. International Journal of Molecular Sciences, 25(17). https://doi.org/10.3390/ijms25179506 (Review)